ClariTrial | Search Clinical Trials

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

240 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study

Phase 2Atopic Dermatitis

Oral roflumilast

Nora Mohamed Abdelrazik36 participants1 site · EgyptCompletes May 2026

Compare CT.gov Full analysis →

Recruiting

A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment

N/ADermatitis Atopic

Dupilumab

Sanofi150 participants9 sites · ItalyCompletes Jan 2026

Compare CT.gov Full analysis →

Recruiting

CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

N/AAtopic Dermatitis

CorEvitas1,500 participants1 site · United StatesCompletes Dec 2099

Compare CT.gov Full analysis →

Recruiting

Characterization of Chronic Hand Eczema

N/AChronic Hand EczemaAtopic Dermatitis

Tape stripping

Dr. Robert Bissonnette270 participants1 site · CanadaCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Skin Microbial Ecology in Atopic Dermatitis

N/AAtopic DermatitisPsoriasisHealthy

AD subject visit sampling proceduresPS subject visit sampling proceduresHealthy control visit sampling procedures

University of Rochester240 participants1 site · United StatesCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

Phase 1Atopic Dermatitis

BBT001Placebo

Bambusa Therapeutics63 participants10 sites · ChinaCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma

Phase 3MediciineSystemic Sclerosis (SSc)Intervention Study

10% urea lotion plus 1% cannabidiolControl

Khon Kaen University36 participants1 site · ThailandCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Swiss Itch Registry

N/APruritus

Data collection

University Hospital, Basel, Switzerland100 participants1 site · SwitzerlandCompletes Oct 2033

Compare CT.gov Full analysis →

Recruiting

Molecular Signatures of Cutaneous Dupilumab Response

Phase 4Atopic Dermatitis

Dupilumab

University of California, San Francisco15 participants1 site · United StatesCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis

N/AAtopic Dermatitis

Dupilumab

Sanofi184 participants1 site · United Arab EmiratesCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases

N/AAtopic Disorders

not applicable, observational study

Charite University, Berlin, Germany600 participants1 site · GermanyCompletes Aug 2025

Compare CT.gov Full analysis →

Recruiting

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

N/APregnancy RelatedAtopic Dermatitis

Ruxolitinib CreamTCS

Incyte Corporation5,621 participants1 site · United StatesCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

Tissue Repository: CTCL Collection Protocol

N/ALymphoma, T-Cell, CutaneousLymphomatoid PapulosisSézary Syndrome

Columbia University400 participants1 site · United StatesCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis

Phase 3Dermatitis, Atopic

611Matching placebo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.180 participants3 sites · ChinaCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma

Phase 3AsthmaRespiratory Tract InfectionsGastrointestinal Infection

n-3 fatty acidRape seed oil

Professor Klaus Bønnelykke2,000 participants1 site · DenmarkCompletes Oct 2026

Compare CT.gov Full analysis →

1–15 of 240

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

240 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study

Phase 2Atopic Dermatitis

Oral roflumilast

Nora Mohamed Abdelrazik36 participants1 site · EgyptCompletes May 2026

Compare CT.gov Full analysis →

Recruiting

A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment

N/ADermatitis Atopic

Dupilumab

Sanofi150 participants9 sites · ItalyCompletes Jan 2026

Compare CT.gov Full analysis →

Recruiting

CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

N/AAtopic Dermatitis

CorEvitas1,500 participants1 site · United StatesCompletes Dec 2099

Compare CT.gov Full analysis →

Recruiting

Characterization of Chronic Hand Eczema

N/AChronic Hand EczemaAtopic Dermatitis

Tape stripping

Dr. Robert Bissonnette270 participants1 site · CanadaCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Skin Microbial Ecology in Atopic Dermatitis

N/AAtopic DermatitisPsoriasisHealthy

AD subject visit sampling proceduresPS subject visit sampling proceduresHealthy control visit sampling procedures

University of Rochester240 participants1 site · United StatesCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

Phase 1Atopic Dermatitis

BBT001Placebo

Bambusa Therapeutics63 participants10 sites · ChinaCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma

Phase 3MediciineSystemic Sclerosis (SSc)Intervention Study

10% urea lotion plus 1% cannabidiolControl

Khon Kaen University36 participants1 site · ThailandCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Swiss Itch Registry

N/APruritus

Data collection

University Hospital, Basel, Switzerland100 participants1 site · SwitzerlandCompletes Oct 2033

Compare CT.gov Full analysis →

Recruiting

Molecular Signatures of Cutaneous Dupilumab Response

Phase 4Atopic Dermatitis

Dupilumab

University of California, San Francisco15 participants1 site · United StatesCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis

N/AAtopic Dermatitis

Dupilumab

Sanofi184 participants1 site · United Arab EmiratesCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases

N/AAtopic Disorders

not applicable, observational study

Charite University, Berlin, Germany600 participants1 site · GermanyCompletes Aug 2025

Compare CT.gov Full analysis →

Recruiting

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

N/APregnancy RelatedAtopic Dermatitis

Ruxolitinib CreamTCS

Incyte Corporation5,621 participants1 site · United StatesCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

Tissue Repository: CTCL Collection Protocol

N/ALymphoma, T-Cell, CutaneousLymphomatoid PapulosisSézary Syndrome

Columbia University400 participants1 site · United StatesCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis

Phase 3Dermatitis, Atopic

611Matching placebo

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.180 participants3 sites · ChinaCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma

Phase 3AsthmaRespiratory Tract InfectionsGastrointestinal Infection

n-3 fatty acidRape seed oil

Professor Klaus Bønnelykke2,000 participants1 site · DenmarkCompletes Oct 2026

Compare CT.gov Full analysis →

1–15 of 240